Zhang's team wins patent fight for CRISPR gene-editing technology

The United States Patent Trial and Appeal Board has handed a win to Chinese-American synthetic biologist Feng Zhang (張鋒) and his team from the Massachusetts Institute of Technology (MIT) in a dispute over patents of the gene editing technology known as CRISPR.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)